Is There Always a Right or Wrong?: Comments on the FDA Warnings About Triptans and the Serotonin Syndrome

J Clin Psychopharmacol. 2018 Dec;38(6):545-546. doi: 10.1097/JCP.0000000000000965.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Labeling*
  • Humans
  • Research Design
  • Serotonin Syndrome / chemically induced*
  • Serotonin Syndrome / diagnosis
  • Tryptamines / administration & dosage
  • Tryptamines / adverse effects*
  • United States
  • United States Food and Drug Administration

Substances

  • Tryptamines